A cannabis B2B supply agreement is the contractual foundation of every LP-to-importer or LP-to-distributor relationship. Without the right clauses, even a well-executed export can collapse at the point of delivery: a batch held at customs because the agreement lacked a force majeure clause, or a partnership that unravels because neither party defined what happens when a COA fails a receiving-country specification.
Canadian Licensed Producers entering distribution agreements in 2026 face a more complex contracting environment than five years ago. Germany's fully operational medical market, Australia's TGA-regulated supply chain, and Israel's IMC-GMP framework each introduce jurisdiction-specific obligations that a generic commercial contract doesn't address. Getting the agreement right before the first shipment saves months of renegotiation and protects both parties when something inevitably goes off-script.
This guide covers what a cannabis B2B supply agreement must include when you're a Canadian LP shipping to international distributors or pharmacy networks, and how to structure terms that hold up under regulatory scrutiny on both sides.
Regulatory compliance obligations and quality specifications
Every cannabis supply agreement between a Canadian LP and an international buyer must open with a compliance obligations clause. This section names the specific regulatory frameworks governing the relationship and assigns compliance responsibility unambiguously.
On the Canadian side, the Cannabis Act and the Cannabis Regulations govern how product is cultivated, tested, packaged, and exported. The LP holds the export authorisation and bears primary responsibility for meeting Health Canada requirements. The agreement should state this explicitly rather than leaving it implied.
On the buyer's side, the clause needs to name the relevant import framework. For German buyers, that means the Medizinal-Cannabisgesetz and the permit process administered by BfArM. Australian distributors operate under the Therapeutic Goods Administration and the Office of Drug Control. Israeli counterparts require compliance with the Israel Medical Cannabis Agency and IMC-GMP standards.
The clause should also address the Single Convention on Narcotic Drugs and the requirement for import/export certificates under Article 31. Both parties should acknowledge that the agreement is contingent on valid permits being in place before each shipment. Without that acknowledgement, a cancelled permit creates an ambiguous breach scenario.
Quality specifications and testing standards
Define the batch specifications the product must meet at point of shipment. A written specification schedule attached to the agreement is what gets enforced when a shipment is rejected, not an email thread. This should cover:
- Potency ranges (THC/CBD min/max)
- Moisture content and water activity limits
- Microbial and pesticide maximum residue levels per the receiving jurisdiction
- Packaging format (flower grade, bulk weight, unit format)
- Testing standards, with ISO/IEC 17025-accredited lab results required
Certificate of analysis requirements and rejection protocol
The COA clause is where most cannabis supply agreements fall short. A well-drafted COA clause defines four things: who issues the COA (a third-party accredited lab, not an in-house test), the required panel of tests, the maximum age of the COA at point of shipment, and what happens when the buyer's receiving-country lab retests and returns different values.
That last point is the one most agreements get wrong. When a batch tests to spec in Montreal and tests out-of-spec in a Berlin pharmacy lab, both COAs can be technically valid. Different labs, different methodologies, different acceptable deviations. Your agreement needs a tolerance clause: define an acceptable variance percentage (typically 10 to 15% on potency) and a formal retesting protocol using a mutually agreed third-party lab when the variance exceeds that threshold.
Rejection and return terms
Define the rejection window (how many days after delivery the buyer can reject a batch) and the return or destruction protocol. Return shipping of controlled substances across borders is a regulatory event in its own right and requires fresh permits. Most agreements default to in-country destruction with documented chain of custody. Either option should specify who bears the cost and what documentation is required.
AlphaLeaf batches carry full traceability from cultivation through export, with single-batch COAs issued by an ISO/IEC 17025-accredited lab and traceability codes keyed to each unit. From our shipments to regulated markets, that documentation trail has consistently shortened resolution timelines when receiving-country queries come in. You should expect the same standard from any supplier you work with.
See also our guide on how to read a cannabis certificate of analysis for a breakdown of what each panel result means in a B2B procurement context.
Supply terms, pricing structure, and force majeure
Fixed-volume contracts are standard in pharmaceutical supply, but cannabis is a market where production variability still matters. A well-structured supply agreement gives both parties enough certainty to plan without locking the LP into delivery obligations it can't meet if a crop cycle underperforms.
A tiered approach works well in practice:
- A minimum annual volume (the floor the buyer can rely on for their dispensing contracts)
- A maximum annual volume (the ceiling the LP commits to prioritise for this buyer)
- A rolling 90-day forecast window so both sides can adjust quarter by quarter
Pricing can be fixed per kilogram, indexed to a reference rate, or structured as cost-plus. In international agreements, specify whether the price is FOB (Free on Board at the Canadian port of departure) or DAP (Delivered at Place, meaning the LP carries freight and customs risk to a named destination). The two are materially different risk allocations. Most Canadian LP agreements use FOB; European buyers often prefer DAP.
Force majeure: cannabis-specific inclusions
The Cannabis Act grants Health Canada authority to suspend or revoke an LP's export licence, which is a government-imposed force majeure event outside either party's control. Your agreement should explicitly cover:
- Health Canada licence suspension or revocation
- Import permit denial or cancellation by the receiving jurisdiction
- INCB quota restrictions affecting export volume
- Natural disaster, pandemic, or critical infrastructure failure
Include a notice requirement (typically 5 business days) and a resolution window. If the force majeure event persists beyond a defined period, usually 90 to 180 days, either party should have the right to terminate without penalty.
Currency and payment terms
Specify the invoicing currency and which party carries exchange rate risk. USD is the most common denominator for international cannabis trade, though European buyers often request EUR invoicing. Payment terms of net 30 to net 45 are standard, via wire transfer through a compliant banking channel. Include a late payment penalty rate so the timeline has teeth.
Term, termination, and dispute resolution
A supply agreement for a new LP-distributor relationship typically runs 12 to 24 months, with an option to renew on 60 to 90 days notice before expiry. Don't make renewal fully automatic; a pricing review clause that activates at renewal keeps terms fair over time without requiring a full renegotiation.
Termination for cause vs convenience
Termination for cause (breach of compliance obligations, persistent COA failures, non-payment) should have a short cure window: 10 to 15 business days for minor breaches, immediate termination rights for regulatory violations. Termination for convenience should require a longer notice period, at least 90 to 120 days, to give both parties time to arrange alternative supply or find a new buyer.
Include a wind-down clause that governs outstanding orders, in-transit shipments, and pre-paid deposits during the notice period. This is the clause that prevents a messy exit from becoming a legal dispute.
Governing law and arbitration
For contracts between a Canadian LP and a foreign buyer, governing law is a real choice that both parties need to make intentionally. Canadian LPs often prefer Ontario or Quebec law; European buyers may prefer a neutral seat such as Switzerland or the Netherlands. What matters is agreeing on it before there's a dispute.
International arbitration under ICC, LCIA, or SIAC rules is usually preferable to litigation for cross-border cannabis disputes: faster, private, and enforceable in most jurisdictions under the New York Convention. Specify the seat of arbitration, the governing rules, the language, and the number of arbitrators. Three arbitrators for high-value agreements; a sole arbitrator typically suffices for contracts under CAD 500,000.
If you're earlier in your supplier evaluation process, our guide on how to vet a Canadian cannabis LP covers the due diligence steps before a contract is signed. For export-specific requirements to key markets, see our guides on exporting cannabis to Germany and exporting cannabis to Australia.
AlphaLeaf operates under a Health Canada export authorisation with full batch traceability, ISO/IEC 17025-certified testing, and established supply relationships across Germany, Australia, and Israel. If you're structuring a supply agreement with a new LP partner, we're available to discuss how our processes map to the contract terms that matter most to international buyers. Reach out via our international enquiry form.
Frequently Asked Questions
Does a cannabis B2B supply agreement need to reference Health Canada permits specifically?
Yes. Because cannabis is a controlled substance under the Cannabis Act, a supply agreement between a Canadian LP and an international buyer should explicitly reference Health Canada export authorisation requirements and make each shipment contingent on valid export permits being issued. A generic commercial sales agreement does not reflect the regulatory conditions that govern the transaction.
What should a COA clause include in a cannabis supply agreement?
A COA clause should specify the accrediting standard required for the testing laboratory (typically ISO/IEC 17025), the full panel of tests required (potency, microbials, heavy metals, pesticides, residual solvents), the maximum age of the COA at point of shipment, and a formal retesting and variance tolerance protocol for cases where the receiving-country lab returns different values.
How should force majeure be defined in a cannabis export contract?
Force majeure in a cannabis export agreement should cover Health Canada licence suspension or revocation, import permit denial by the receiving jurisdiction, INCB quota restrictions, and standard events such as natural disaster or pandemic. Include a notice obligation, a resolution window, and a right to terminate if the event extends beyond a defined period, typically 90 to 180 days.
What governing law should a Canadian LP choose for an international cannabis supply contract?
There's no single right answer. Canadian LPs often prefer Ontario or Quebec law; European buyers may prefer a neutral jurisdiction such as Switzerland. Agreeing on governing law and a dispute resolution mechanism (ideally international arbitration) before a dispute arises is what matters most.
Who bears export shipping risk under an FOB vs DAP structure?
Under an FOB (Free on Board) structure, risk passes to the buyer when product is loaded at the Canadian port of departure, and the buyer bears freight, insurance, and customs costs from that point. Under a DAP (Delivered at Place) structure, the LP retains risk and bears cost until the product reaches a named destination. Most Canadian LPs use FOB; European buyers may prefer DAP for supply chain simplicity.
